Literature DB >> 16614281

Detection of functional differences between different platelet membrane glycoprotein Ibalpha variable number tandem repeat and Kozak genotypes as shown by the PFA-100 system.

H Douglas, G J Davies, K Michaelides, D A Gorog, H Timlin, N Ahmed, E G D Tuddenham.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16614281      PMCID: PMC1860909          DOI: 10.1136/hrt.2004.058545

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

1.  Platelet membrane glycoprotein Ibalpha gene -5T/C Kozak sequence polymorphism as an independent risk factor for the occurrence of coronary thrombosis.

Authors:  H Douglas; K Michaelides; D A Gorog; E Durante-Mangoni; N Ahmed; G J Davies; E G D Tuddenham
Journal:  Heart       Date:  2002-01       Impact factor: 5.994

2.  The risk of coronary occlusion is not proportional to the prior severity of coronary stenoses.

Authors:  J A Ambrose; V Fuster
Journal:  Heart       Date:  1998-01       Impact factor: 5.994

Review 3.  Molecular mechanisms of platelet adhesion and activation.

Authors:  R K Andrews; J A López; M C Berndt
Journal:  Int J Biochem Cell Biol       Date:  1997-01       Impact factor: 5.085

4.  The variable number of tandem repeat polymorphism of platelet glycoprotein Ibalpha and risk of coronary heart disease.

Authors:  Vahid Afshar-Kharghan; Nevenka Matijevic-Aleksic; Chul Ahn; Eric Boerwinkle; Kenneth K Wu; José A López
Journal:  Blood       Date:  2003-10-30       Impact factor: 22.113

5.  Polymorphisms of platelet membrane glycoprotein Ib associated with arterial thrombotic disease.

Authors:  R Gonzalez-Conejero; M L Lozano; J Rivera; J Corral; J A Iniesta; J M Moraleda; V Vicente
Journal:  Blood       Date:  1998-10-15       Impact factor: 22.113

  5 in total
  1 in total

Review 1.  The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19.

Authors:  Yao Yang; Joshua P Lewis; Jean-Sébastien Hulot; Stuart A Scott
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-07-14       Impact factor: 4.481

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.